Abstract:In autosomal dominant polycystic kidney disease (ADPKD), the inexorable growth of numerous fluid-filled cysts leads to massively enlarged kidneys, renal interstitial damage, inflammation, and fibrosis, and progressive decline in kidney function. It has long been recognized that interstitial fibrosis is the most important manifestation associated with end-stage renal disease; however, the role of abnormal extracellular matrix (ECM) production on ADPKD pathogenesis is not fully understood. Early evidence showed that cysts in end-stage human ADPKD kidneys had thickened and extensively laminated cellular basement membranes, and abnormal regulation of gene expression of several basement membrane components, including collagens, laminins, and proteoglycans by cyst epithelial cells. These basement membrane changes were also observed in dilated tubules and small cysts of early ADPKD kidneys, indicating that ECM alterations were early features of cyst development. Renal cystic cells were also found to overexpress several integrins and their ligands, including ECM structural components and soluble matricellular proteins. ECM ligands binding to integrins stimulate focal adhesion formation and can promote cell attachment and migration. Abnormal expression of laminin-332 (laminin-5) and its receptor α6β4 stimulated cyst epithelial cell proliferation; and mice that lacked laminin α5, a component of laminin-511 normally expressed by renal tubules, had an overexpression of laminin-332 that was associated with renal cyst formation. Periostin, a matricellular protein that binds αVβ3- and αVβ5-integrins, was found to be highly overexpressed in the kidneys of ADPKD and autosomal recessive PKD patients, and several rodent models of PKD. αVβ3-integrin is also overexpressed by cystic epithelial cells, and the binding of periostin to αVβ3-integrin activates the integrin-linked kinase and downstream signal transduction pathways involved in tissue repair promoting cyst growth, ECM synthesis, and tissue fibrosis. This chapter reviews the roles of the ECM, integrins, and focal adhesion signaling in cyst growth and fibrosis in PKD.

Signal Transduction Pathways Involved in the Pathogenesis of Autosomal Dominant Polycystic Kidney Disease

The Advances of Polycystin-1

Wnt signaling pathway and the pathogenesis of autosomal dominant polycystic kidney disease

Autosomal Dominant Polycystic Kidney Disease with Ectopic Unilateral Multicystic Dysplastic Kidney

Advances in autosomal dominant polycystic kidney disease

[Mechanisms of polycystic kidney diseases inducing male reproductive disorders].

Mechanistic complement of autosomal dominant polycystic kidney disease: the role of aquaporins

Polycystic Kidney Disease: Novel Insights into Polycystin Function.

Progress in Treatment of Autosomal Dominant Polycystic Kidney Disease

Modulation of polycystic kidney disease by G-protein coupled receptors and cyclic AMP signaling

Activation of P-TEFb by cAMP-PKA signaling in autosomal dominant polycystic kidney disease

Clinical Findings, Underlying Pathogenetic Processes and Treatment of Vascular Dysfunction in Autosomal Dominant Polycystic Kidney Disease

Insights into Autosomal Dominant Polycystic Kidney Disease from Genetic Studies

A RhoA–YAP–c-Myc signaling axis promotes the development of polycystic kidney disease

Cross-Species Insights into Autosomal Dominant Polycystic Kidney Disease: Provide an Alternative View on Research Advancement.

The Genetic and Cellular Basis of Autosomal Dominant Polycystic Kidney Disease-A Primer for Clinicians

Extracellular matrix, integrins, and focal adhesion signaling in polycystic kidney disease

Extracellular vesicles and exosomes generated from cystic renal epithelial cells promote cyst growth in autosomal dominant polycystic kidney disease

Up-Regulation of DNA Damage Response Signaling in Autosomal Dominant Polycystic Kidney Disease

EZH2 inhibition or genetic ablation suppresses cyst growth in autosomal dominant polycystic kidney disease

Provide an Alternative View on Research Advancement